The TOUR has opened the door for players it would love to have back, while leaving over-the-hill, aging veterans and unproven youngsters to fend for themselves.
Cardiff Oncology (CRDF) remains a single-asset biotech, with its thesis reliant on onvansertib targeting PLK1 in difficult-to ...
Delicate features, uneven surfaces, and extreme density make it difficult to manage probe force and ensure reliability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback